Correlation Between Keros Therapeutics and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Keros Therapeutics and Processa Pharmaceuticals, you can compare the effects of market volatilities on Keros Therapeutics and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Processa Pharmaceuticals.

Diversification Opportunities for Keros Therapeutics and Processa Pharmaceuticals

0.75

Correlation Coefficient

Keros Therapeutics  Processa Pharmaceuticals

Poor diversification

The 3 months correlation between Keros and Processa is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Keros Therapeutics and Processa Pharmaceuticals

Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.78 times more return on investment than Processa Pharmaceuticals. However, Keros Therapeutics is 1.28 times less risky than Processa Pharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.28 per unit of risk. If you would invest  1,564  in Keros Therapeutics on December 29, 2024 and sell it today you would lose (465.00) from holding Keros Therapeutics or give up 29.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Keros Therapeutics  vs.  Processa Pharmaceuticals

Keros Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Keros Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Processa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Keros Therapeutics and Processa Pharmaceuticals

The main advantage of trading using opposite Keros Therapeutics and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Keros Therapeutics and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.